InsiderTrades

Form 4 for MIRM Mirum Pharmaceuticals, Inc.

Accepted 2025-08-12 00:00:00 ET · period of report 2025-08-11 · accession 0001415889-25-021522 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-08-12 2025-08-12 MIRM BJERKHOLT ERIC CFO M - OptEx $26.49 +2,954 31.2K +10% +$78.3K
D 2025-08-12 2025-08-11 MIRM BJERKHOLT ERIC CFO S - Sale+OE — -8,000 28.2K -22% —
D 2025-08-12 2025-08-12 MIRM BJERKHOLT ERIC CFO M - OptEx $0.00 -2,954 29.0K -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-12 M A 2,954 $26.49 31,190 D — —
2 Common Common Stock 2025-08-11 S D 8,000 — 28,236 D — — (F1) The weighted average sale price for the transaction reported was $65.50, and the range of prices were between $65.31 and $66.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. (F2) Includes 290 shares of Common Stock that were acquired by the Reporting Person on May 10, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.
3 Derivative Employee Stock Option (right to buy) 2025-08-12 M D 2,954 $0.00 29,046 D $26.49 · — to 2034-01-22 2,954 Common Stock (F3) 1/4th of the shares vested one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.